Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
celecoxib (celebrex) (1 trial)
vinblastine (velban) (1 trial)
adenoviral vector encoding rat her-2/neu (1 trial)
adher-2/neu transduced dendritic cells (1 trial)
autologous cd34+ cells (1 trial)
Breast Neoplasms (Phase 1)
Colorectal Neoplasms (Phase 2)
Glioma (Phase 2)
Trials (5 total)
Trial APIs (5 total)